WilmerHale Represents Medtronic in its $2.0B Offering of Senior Notes

WilmerHale Represents Medtronic in its $2.0B Offering of Senior Notes

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Comprehensive counseling for healthcare providers, insurers and the companies that supply them with products and services.

WilmerHale represented Medtronic Global Holdings S.C.A., a wholly-owned subsidiary of Medtronic plc, a global leader in healthcare technology, in connection with its recent public offering of $1.0 billion aggregate principal amount of 4.250% Senior Notes due 2028 and $1.0 billion aggregate principal amount of 4.500% Senior Notes due 2033. Net proceeds from the offering will be used to repay outstanding indebtedness. The transaction closed on March 30, 2023.

The WilmerHale team representing Medtronic was led by corporate partners Erika Robinson, Justin Ochs and Craig Hilts, counsel Andrew Langworthy, senior associate Leigh Krafchek, associate Shaina Hourizadeh, and included associate Ben Lobley.

For more information, read Medtronic’s press release.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel